Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel

被引:111
作者
Constantinides, PP [1 ]
Lambert, KJ [1 ]
Tustian, AK [1 ]
Schneider, B [1 ]
Lalji, S [1 ]
Ma, WW [1 ]
Wentzel, B [1 ]
Kessler, D [1 ]
Worah, D [1 ]
Quay, SC [1 ]
机构
[1] SONUS Pharmaceut, Bothell, WA 98021 USA
关键词
paclitaxel; emulsions; filter-sterization; particle size; stability;
D O I
10.1023/A:1007565230130
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Paclitaxel is currently administered i.v. as a slow infusion of a solution of the drug in an ethanol:surfactant:saline admixture. However, poor solubilization and toxicity are associated with this drug therapy. Alternative drug delivery systems, including parenteral emulsions, are under development in recent years to reduce drug toxicity, improve efficacy and eliminate premedication. Methods. Paclitaxel emulsions were prepared by high-shear homogenization. The particle size of the emulsions was measured by dynamic light scattering. Drug concentration was quantified by HPLC and in vitro drug release was monitored by membrane dialysis. The physical stability of emulsions was monitored by particle size changes in both the mean droplet diameter and 99% cumulative distribution. Paclitaxel potency and changes in the concentration of known degradants were used as chemical stability indicators. Single dose acute toxicity studies were conducted in healthy mice and efficacy studies in B16 melanoma tumor-bearing mice. Results. QW8184, a physically and chemically stable sub-micron oil-in-water (o/w) emulsion of paclitaxel, can be prepared at high drug loading (8-10 mg/mL) having a mean droplet diameter of <100 nm and 99% cumulative particle size distribution of <200 nm. In vitro release studies demonstrated low and sustained drug release both in the presence and absence of human serum albumin. Based on single dose acute toxicity studies, QW8184 is well tolerated both in mice and rats with about a 3-fold increase in the maximum-tolerated-dose (MTD) over the current marketed drug formulation. Using the B16 mouse melanoma model, a significant improvement in drug efficacy was observed with QW8184 over Taxol(R). Conclusions. QW8184,a stable sub-micron o/w emulsion of paclitaxel has been developed that can be filter-sterilized and administered i.v. as a bolus dose. When compared to Taxol(R), this emulsion exhibited reduced toxicity and improved efficacy most likely due to the composition and dependent physicochemical characteristics of the emulsion.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 34 条
[1]  
AHMAD I, 1999, P AM ASSOC CANC RES, V40, P3849
[2]   A MIXED MICELLAR FORMULATION SUITABLE FOR THE PARENTERAL ADMINISTRATION OF TAXOL [J].
ALKANONYUKSEL, H ;
RAMAKRISHNAN, S ;
CHAI, HB ;
PEZZUTO, JM .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :206-212
[3]  
BISSERY MC, 1991, CANCER RES, V51, P4845
[4]  
COLLINS-GOLD L C, 1990, Advanced Drug Delivery Reviews, V5, P189, DOI 10.1016/0169-409X(90)90016-L
[5]  
CONSTANTINIDES PP, 1998, PHARM SCI, V1, pS100
[6]   SUSPECTED ANAPHYLACTIC REACTION TO CREMOPHOR EL [J].
DYE, D ;
WATKINS, J .
BRITISH MEDICAL JOURNAL, 1980, 280 (6228) :1353-1353
[7]  
GEETHA A, 1990, Indian Journal of Physiology and Pharmacology, V34, P94
[8]  
GOKHALE PC, 1999, P AM ASSOC CANC RES, V40, P2759
[9]  
HARVEY SD, 1991, J CHROMATOGR, V582, P273
[10]  
HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134